Are proton pump inhibitors safe during pregnancy and lactation?: Evidence to date

Drugs

Volumn 72, Issue 2, 2012, Pages 171-179

  Majithia, Raj ^a   Johnson, David A ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Alginate; Antacids; Breast feeding; Breast milk; Dexlansoprazole; Esomeprazole; Gastro oesophageal reflux; Heartburn; Histamine H2 receptor antagonists; Lactation; Lansoprazole; Omeprazole; Pantoprazole; Pregnancy; Proton pump inhibitors; Rabeprazole; Teratogenesis

Indexed keywords

ALGINIC ACID; ANTACID AGENT; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE;

ANALGESIA; APGAR SCORE; BIRTH DEFECT; BIRTH WEIGHT; BLEEDING; BREAST MILK; CONGENITAL MALFORMATION; DRUG SAFETY; ENDOSCOPY; ESOPHAGITIS; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGOGRAPHY; FETUS HEART RATE; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; FOOD AND DRUG ADMINISTRATION; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LACTATION; LOW BIRTH WEIGHT; NONHUMAN; OXYGEN SATURATION; PATIENT CARE; PREGNANCY; PRENATAL DRUG EXPOSURE; REVIEW; SECOND TRIMESTER PREGNANCY; SEDATION; SIDE EFFECT; SLEEP PATTERN; THIRD TRIMESTER PREGNANCY;

FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; LACTATION; PREGNANCY; PREGNANCY COMPLICATIONS; PROTON PUMP INHIBITORS;

EID: 84862924709     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11597290-000000000-00000     Document Type: Review

References (37)

1. Raghunath AS, O'Morain C, McLoughlin RC. Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther 2005; 22 Suppl. 1: 55-63 (Pubitemid 41153080)
2. Richter JE. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin NA 2003; 32: 235-61 (Pubitemid 36292708)
3. Ali R, Egan L. Gastroesophageal reflux disease in pregnancy. Best Pract Res Clin Gastroenterol 2007; 21: 793-806 (Pubitemid 47413168)
4. Broussard C, Richter J. Treating gastro-oesophageal reflux during pregnancy and lactation: what are the safest therapy options? Drug Saf 1998; 19: 325-37 (Pubitemid 28484420)
5. Mahadevan U. Gastrointestinal medications in pregnancy. Best Pract Res Clin Gastroenterol 2007; 21: 849-77 (Pubitemid 47413173)
6. Barr W. Heartburn in pregnancy. J Obstet Gynecol British Empire 1958; 65: 1019-21
7. de Castro LP. Reflux esophagitis as the cause of heartburn in pregnancy. Am J Obstet Gynecol 1967; 98: 1-10
8. Marrero JM, GogginPM, de Caestecker JS, et al. Determinants of pregnancy heartburn. Br J Obstet Gynaecol 1992; 99: 731-4
9. Katz PO, Castell DO. Gastroesophageal reflux disease during pregnancy. Gastro Clin NA 1998; 27: 153-67 (Pubitemid 28156193)
10. VanThiel DH, Gavaler JS, Joshi SN, et al. Heartburn of pregnancy. Gastroenterology 1977; 72: 668-78
11. Lind JF, Smith AM, McKiver DK, et al. Heartburn in pregnancy: a manometry study. CMAJ 1968; 98: 571-4
12. Ulmsten U, Sundstrom G. Esophageal manometry in pregnant and nonpregnant women. Am J Obstet Gynecol 1978; 132: 260-4 (Pubitemid 8399407)
13. Wald A, Van Thiel DH, Hoechstetter BS, et al. Effects of pregnancy on gastrointestinal transit. Dig Dis Sci 1982; 27: 1015-8
14. Cappell MS. Sedation and analgesia for gastrointestinal endoscopy during pregnancy.Gastro Endo Clinics 2006; 16 (1): 1-31 (Pubitemid 44389627)
15. Capell MS, Colon VJ, Sidhom OA. A study of eight medical centers on the safety and clinical efficacy of esophagogastroduodenoscopy in 83 pregnant females with follow-ups of fetal outcome and with comparison to control groups. Am J Gastroenterol 1996; 91: 348-54 (Pubitemid 26067347)
16. Qureshi WA, Rajan E, Adler DG, et al. ASGE guideline: guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc 2005; 61 (3): 357-62 (Pubitemid 40349025)
17. Gill SK, O'brien L, Einarson T, et al. The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastro 2009; 104: 1541-5
18. Pasternak B, Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med 2010; 363 (22): 2114-23
19. The Swedish Association of the Pharmaceutical Industry. FASS-the Swedish Medicines Information Engine [online]. Available from URL: http://www.lif.se/ default.aspx?id=31983 [Accessed 2011 Dec 15]
20. Friedman JM, Polifka JE. Teratogenic effects of drugs: a resource for clinicians (TERIS). 2nd ed. Baltimore (MD): The Johns Hopkins University Press, 2000: 516
21. Kallen B. Use of omeprazole during pregnancy: no hazard demonstrated in 955 infants exposed during pregnancy. Eur Obstet Gynecol Reprod Biol 2001; 96 (1): 63-8 (Pubitemid 32331852)
22. Kallen B. Drugs during pregnancy. New York: Nova Biomedical Books, 2009: 39-47
23. Lalkin A, Loebbstein R, Addis A, et al. The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am J Obstet Gynecol 1998; 179: 727-30 (Pubitemid 28447254)
24. Ruigomez A, Rodriguez LUG, Cattaruzzi C, et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol 1999; 150: 476-81 (Pubitemid 29407231)
25. Nielsen GL, Sorensen HT, Tage-Jensen A, et al. The safety of proton pump inhibitors in pregnancy. Aliment Pharmacol Ther 1999; 13: 1085-9 (Pubitemid 29374110)
26. Prilosec [product information]. Wilmington (DE): Astra-Zeneca, 2011
27. Prevacid [product information]. Lake Forest (IL): TAP Pharmaceuticals, 2008
28. Esomeprazole [product information]. Wilmington (DE): AstraZeneca, 2010
29. Dexilant [product information]. Deerfield (IL): Takeda Pharmaceuticals, 2011
30. Protonix [product information]. Philadelphia (PA): Wyeth Pharmaceuticals, 2010
31. Aciphex [product information]. Raritan (NJ): PRICARA, 2010
32. Marshall JK, Thomason ABR, Armstrong D. Omeprazole for refractory gastroesophageal reflux disease during pregnancy and lactation. Can J Gastroenterol 1998; 12: 225-7 (Pubitemid 28182016)
33. Diav-Citran O, Arnon J, Shechtman S, et al. The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther 2005; 21: 269-75 (Pubitemid 40278364)
34. Matok I, Gorodischer R, Koren G, et al. The safety of intrauterine exposure to proton pump inhibitors during the first trimester of pregnancy [abstract]. The IXth World Conference on Clinical Pharmacology and Therapeutics; 2008 Jul 27-Aug; Quebec City (QC)
35. Nikfar S, AbdollahiM,Moretti M, et al. Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis. Dig Dis Sci 2002; 47: 1526-9 (Pubitemid 34753932)
36. Nielson G, Sorenson H, Thulstrup A, et al. The safety of proton pump inhibitors in pregnancy. Aliment Pharmacol Ther 1999; 12: 1085-9 (Pubitemid 29374110)
37. Revicki DA, Zodet MW, Joshua-Gotlib S, et al. Healthrelated quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity. Health Qual Life Outcomes 2003; 1: 73